Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related
death worldwide. Lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are …

Due to its insidious nature, lung cancer remains a leading cause of cancer-related deaths
worldwide. Therefore, there is an urgent need to identify sensitive/specific biomarkers for …

Background Metabolic reprogramming plays a significant role in the advancement of lung
adenocarcinoma (LUAD), yet the precise metabolic changes remain incompletely …

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer death globally.
More accurate and reliable diagnostic methods/biomarkers are urgently needed. Joint …

Simple Summary Non-small cell lung cancer (NSCLC) is the most severe cancer showing a
low 5-year survival rate of metastatic NSCLC, but there are few previous reports for …

Unclarified molecular mechanism and lack of practical diagnosis biomarkers hinder the
effective treatment of non-small-cell lung cancer. Herein, we performed liquid …

High morbidity and mortality are still associated with lung cancer, especially non-small cell
lung cancer (NSCLC). Although several studies showed abnormality in lung cancer …

Background Non‐small cell lung cancer (NSCLC) comprises the majority (~ 85%) of all lung
tumors, with lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) being the …

Lung cancer is the leading cause of human cancer mortality due to the lack of early
diagnosis technology. The low-dose computed tomography scan (LDCT) is one of the main …

Lung cancer is a common malignancy that is frequently associated with systemic metabolic
disorders. Early detection is pivotal to survival improvement. Although blood biomarkers …